Comments
Loading...

Kestra Medical Techs Analyst Ratings

KMTSNASDAQ
Logo brought to you by Benzinga Data
Q3 2025 earnings announcement after the market close today
Conference call scheduled today at 16:30 PM Click to view the webcast
Consensus Rating1
Overweight
Highest Price Target1
$29.00
Lowest Price Target1
$24.00
Consensus Price Target1
$27.20

Kestra Medical Techs Analyst Ratings and Price Targets | NASDAQ:KMTS | Benzinga

Kestra Medical Technologies Ltd has a consensus price target of $27.2 based on the ratings of 5 analysts. The high is $29 issued by Wolfe Research on March 31, 2025. The low is $24 issued by Goldman Sachs on March 31, 2025. The 3 most-recent analyst ratings were released by Wolfe Research, Wells Fargo, and Stifel on March 31, 2025, respectively. With an average price target of $28.33 between Wolfe Research, Wells Fargo, and Stifel, there's an implied 18.92% upside for Kestra Medical Technologies Ltd from these most-recent analyst ratings.

Analyst Trends and Forecast
4
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Wolfe Research
Wells Fargo
Stifel
Goldman Sachs
Piper Sandler

1calculated from analyst ratings

Analyst Ratings for Kestra Medical Techs

Buy NowGet Alert
03/31/2025Buy Now21.72%Wolfe Research
Mike Polark54%
→ $29Initiates → OutperformGet Alert
03/31/2025Buy Now17.52%Wells Fargo
Larry Biegelsen67%
→ $28Initiates → OverweightGet Alert
03/31/2025Buy Now17.52%Stifel
Rick Wise73%
→ $28Initiates → BuyGet Alert
03/31/2025Buy Now0.73%Goldman Sachs
David Roman35%
→ $24Initiates → NeutralGet Alert
03/31/2025Buy Now13.33%Piper Sandler
Matt O'Brien49%
→ $27Initiates → OverweightGet Alert

FAQ

Q

What is the target price for Kestra Medical Techs (KMTS) stock?

A

The latest price target for Kestra Medical Techs (NASDAQ:KMTS) was reported by Wolfe Research on March 31, 2025. The analyst firm set a price target for $29.00 expecting KMTS to rise to within 12 months (a possible 21.72% upside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Kestra Medical Techs (KMTS)?

A

The latest analyst rating for Kestra Medical Techs (NASDAQ:KMTS) was provided by Wolfe Research, and Kestra Medical Techs initiated their outperform rating.

Q

When was the last upgrade for Kestra Medical Techs (KMTS)?

A

There is no last upgrade for Kestra Medical Techs

Q

When was the last downgrade for Kestra Medical Techs (KMTS)?

A

There is no last downgrade for Kestra Medical Techs.

Q

When is the next analyst rating going to be posted or updated for Kestra Medical Techs (KMTS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kestra Medical Techs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kestra Medical Techs was filed on March 31, 2025 so you should expect the next rating to be made available sometime around March 31, 2026.

Q

Is the Analyst Rating Kestra Medical Techs (KMTS) correct?

A

While ratings are subjective and will change, the latest Kestra Medical Techs (KMTS) rating was a initiated with a price target of $0.00 to $29.00. The current price Kestra Medical Techs (KMTS) is trading at is $23.83, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch